SCHEMBL1639175

SCHEMBL1639175

O=C(c1cc(Cl)ccc1NC(C(=O)O)c1cc2ccccc2o1)C(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
ATM Q13315 1/20 0.43
MAOB P27338 4/20 0.38
ACHE P22303 1/20 0.38
MAPT P10636 2/20 0.38
TDP1 Q9NUW8 2/20 0.37
MAOA P21397 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
CCR2 P41597 5/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 1/20 0.36
KCNH2 Q12809 1/20 0.35
PPARG P37231 1/20 0.35
TSHR P16473 2/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7997523 0.87 NPC1 (0.43) NPC1RAB9AATMMAOBACHE
SCHEMBL12725521 0.77 NPC1 (0.44) NPC1RAB9AATMMAOBACHE
SCHEMBL2944209 0.76 RAB9A (0.43) NPC1RAB9AATMMAOBACHE
SCHEMBL2944046 0.68 NFKB1 (0.57) NPC1RAB9AMAOBMAOASMN1; SMN2
SCHEMBL13522922 0.65 MAPT (0.49) RAB9AMAPTMAOAL3MBTL1SMN1; SMN2
SCHEMBL16595668 0.64 KDM4E (0.53) NPC1RAB9AMAOBL3MBTL1SMN1; SMN2
SCHEMBL7577550 0.63 PPARG (0.51) NPC1RAB9AMAPTL3MBTL1SMN1; SMN2
SCHEMBL7583928 0.63 TAS1R3 (0.51) NPC1RAB9AATMMAPTTDP1
SCHEMBL31038829 0.62 ALDH1A1 (0.53) NPC1RAB9AMAOBL3MBTL1SMN1; SMN2
SCHEMBL3810329 0.61 CA1 (0.46) NPC1RAB9AMAOBMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110098483-A1 Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2011-04-28 US disclosed
US-20110098483-A1 Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2011-04-28 US disclosed
WO-2009121033-A2 SUBSTITUTED NITROGEN HETEROCYCLES AND SYNTHESIS AND USES THEREOF UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2009-10-01 WO disclosed
US-20090247766-A1 Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2009-10-01 US disclosed
US-20090247766-A1 Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2009-10-01 US disclosed
US-20090247766-A1 Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098483-A1 Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof PAH, NAT1, NNT NPC1 123/4885RAB9A 1828/4885ATM 2695/4885
US-20090247766-A1 Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof PAH, NAT1, NNT NPC1 123/4885RAB9A 1828/4885ATM 2695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.